AGP Executive Report
Last update: 11 hours agoSleep Research: A Cochrane review says current trials are too limited to show whether medical cannabis, including CBD-THC products, improves insomnia or daytime functioning. Health Risks: Victorian hospital admissions primarily linked to cannabis rose 49% over a decade; psychotic disorders accounted for about 40% of cases, with the sharpest increase among females. CBD & Hemp Rules: Federal changes due Dec. 11 will tighten which cannabinoid products qualify as hemp. CBD itself is not banned, but products containing THC could be affected. Cancer Care: A federally funded study reports medical marijuana improved cancer-related symptoms and helped reduce opioid use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.